Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Assets Average (2016 - 2025)

Editas Medicine (EDIT) has disclosed Assets Average for 10 consecutive years, with $206.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 42.12% to $206.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $206.2 million, a 42.12% decrease, with the full-year FY2024 number at $420.4 million, down 17.04% from a year prior.
  • Assets Average was $206.2 million for Q3 2025 at Editas Medicine, down from $237.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $768.1 million in Q2 2021 to a low of $206.2 million in Q3 2025.
  • A 5-year average of $502.4 million and a median of $503.0 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: skyrocketed 38.67% in 2021, then plummeted 42.53% in 2025.
  • Editas Medicine's Assets Average stood at $697.3 million in 2021, then fell by 25.04% to $522.7 million in 2022, then decreased by 3.97% to $501.9 million in 2023, then crashed by 33.34% to $334.6 million in 2024, then tumbled by 38.38% to $206.2 million in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Assets Average are $206.2 million (Q3 2025), $237.1 million (Q2 2025), and $302.6 million (Q1 2025).